Axsome Therapeutics, Inc. (AXSM)

Axsome Therapeutics Revenue

Axsome Therapeutics had revenue of $218.38M in the quarter ending June 30, 2026, with 45.54% growth. This brings the company's total for the last twelve months to $776.57M, up 56.87% year-over-year. In the year 2025, Axsome Therapeutics had annual revenue of $638.50M with 65.55% growth. That makes Axsome Therapeutics the 8,826th largest company in the world by revenue and 1,965th in the United States.

• Revenue (ttm): $776.57M
• Revenue Growth: +56.87%
• P/S Ratio: 10.76
• Revenue / Employee: $576,946
• Employees: 1,346
• Market Cap: 8.36B

Revenue Chart

Chart

Chart

Revenue by Geography

Chart

• United States 628.62M 98.5%
• Outside of The United States 9.88M 1.5%

Fiscal year ended Dec 31, 2025 See the full Axsome Therapeutics breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	638.50M	252.80M	65.55%
Dec 31, 2024	385.69M	115.09M	42.53%
Dec 31, 2023	270.60M	220.56M	440.80%
Dec 31, 2022	50.04M	-	-
Dec 31, 2021	-	-	-

Data Source: S&P Global Market Intelligence Last updated: Aug 10, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 21, 2026

Data Sources Report a data error